Literature DB >> 27552253

Rutin Prevents High Glucose-Induced Renal Glomerular Endothelial Hyperpermeability by Inhibiting the ROS/Rhoa/ROCK Signaling Pathway.

Xiaoming Wang1, Xiaohong Zhao1, Ting Feng1, Gang Jin1, Zhenjiang Li1.   

Abstract

Diabetic nephropathy is a progressive kidney disease caused by damage to the capillaries in the glomeruli. Endothelial dysfunction is an early sign of diabetic cardiovascular disease and may contribute to progressive diabetic nephropathy. Hyperglycemia-induced endothelial hyperpermeability is crucial to diabetic nephropathy. Rutin has beneficial effects on diabetic nephropathy, but the exact mechanisms of its protective effect remain elusive. The aim of this study was to assess the role of pretreatment with rutin in an in vitro model of hyperglycemia-induced barrier dysfunction in human renal glomerular endothelial cells. Human renal glomerular endothelial cells were exposed to rutin and/or hyperglycemia for 24 h. Hyperglycemia increased permeability and decreased the junction protein occludin in the cell-cell junction area and the total expression in human renal glomerular endothelial cells, whereas rutin treatment significantly corrected these abnormalities. Furthermore, hyperglycemia-induced activation of RhoA/ROCK was reversed by treatment with rutin or the knockdown of ROCK2. Interestingly, rutin prevented hyperglycemia-induced hyperpermeability, and dysfunction of the tight junction, a high level of reactive oxygen species, and activation of RhoA/ROCK were significantly abolished with the knockdown of Nrf2. In conclusion, rutin significantly prevented hyperglycemia-disrupted renal endothelial barrier function by inhibiting the RhoA/ROCK signaling pathway through decreasing reactive oxygen species, which was mediated by the activation of Nrf2. Our results may explain, at least in part, some beneficial effects of rutin that may be applicable to the treatment of vascular disorders in diabetic nephropathy. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27552253     DOI: 10.1055/s-0042-110859

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  13 in total

1.  Liraglutide Ameliorates Erectile Dysfunction via Regulating Oxidative Stress, the RhoA/ROCK Pathway and Autophagy in Diabetes Mellitus.

Authors:  Penghui Yuan; Delin Ma; Xintao Gao; Jiaxing Wang; Rui Li; Zhuo Liu; Tao Wang; Shaogang Wang; Jihong Liu; Xiaming Liu
Journal:  Front Pharmacol       Date:  2020-08-12       Impact factor: 5.810

2.  Rutin inhibits carfilzomib-induced oxidative stress and inflammation via the NOS-mediated NF-κB signaling pathway.

Authors:  Naif O Al-Harbi; Faisal Imam; Mohammed M Al-Harbi; Othman A Al-Shabanah; Moureq Rashed Alotaibi; Homood M As Sobeai; Muhammad Afzal; Imran Kazmi; Ammar Cherkess Al Rikabi
Journal:  Inflammopharmacology       Date:  2019-01-01       Impact factor: 4.473

Review 3.  Role of Nuclear Factor Erythroid 2-Related Factor 2 in Diabetic Nephropathy.

Authors:  Wenpeng Cui; Xu Min; Xiaohong Xu; Bing Du; Ping Luo
Journal:  J Diabetes Res       Date:  2017-04-23       Impact factor: 4.011

4.  A Crude 1-DNJ Extract from Home Made Bombyx Batryticatus Inhibits Diabetic Cardiomyopathy-Associated Fibrosis in db/db Mice and Reduces Protein N-Glycosylation Levels.

Authors:  Qing Zhao; Tian Zhu Jia; Qi Chen Cao; Fang Tian; Wan Tao Ying
Journal:  Int J Mol Sci       Date:  2018-06-07       Impact factor: 5.923

5.  MiR-30c-5p/ROCK2 axis regulates cell proliferation, apoptosis and EMT via the PI3K/AKT signaling pathway in HG-induced HK-2 cells.

Authors:  Lianshun Cui; Meiyan Yu; Xinglei Cui
Journal:  Open Life Sci       Date:  2020-12-23       Impact factor: 0.938

Review 6.  Flavonoids on diabetic nephropathy: advances and therapeutic opportunities.

Authors:  Qichao Hu; Caiyan Qu; Xiaolin Xiao; Wenwen Zhang; Yinxiao Jiang; Zhao Wu; Dan Song; Xi Peng; Xiao Ma; YanLing Zhao
Journal:  Chin Med       Date:  2021-08-07       Impact factor: 5.455

Review 7.  Flavonoids in Kidney Health and Disease.

Authors:  Félix Vargas; Paola Romecín; Ana I García-Guillén; Rosemary Wangesteen; Pablo Vargas-Tendero; M Dolores Paredes; Noemí M Atucha; Joaquín García-Estañ
Journal:  Front Physiol       Date:  2018-04-24       Impact factor: 4.566

8.  Identification of C3 as a therapeutic target for diabetic nephropathy by bioinformatics analysis.

Authors:  ShuMei Tang; XiuFen Wang; TianCi Deng; HuiPeng Ge; XiangCheng Xiao
Journal:  Sci Rep       Date:  2020-08-10       Impact factor: 4.379

9.  Dendropanax morbifera Protects against Renal Fibrosis in Streptozotocin-Induced Diabetic Rats.

Authors:  Richa Sachan; Amit Kundu; Prasanta Dey; Ji Yeon Son; Kyeong Seok Kim; Da Eun Lee; Hae Ri Kim; Jae Hyeon Park; Su Hyun Lee; Jung-Hwan Kim; Shugeng Cao; Byung Mu Lee; Jong Hwan Kwak; Hyung Sik Kim
Journal:  Antioxidants (Basel)       Date:  2020-01-19

Review 10.  Molecular Mechanistic Pathways Targeted by Natural Antioxidants in the Prevention and Treatment of Chronic Kidney Disease.

Authors:  Mohamed Mohany; Mohammed M Ahmed; Salim S Al-Rejaie
Journal:  Antioxidants (Basel)       Date:  2021-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.